Protocol No.: AB06012; A 24-week with possible extension, prospective, multicenter, randomised, double-blind, controlled, 3-parallel groups, Phase 2b/3 study to compare efficacy and safty of masitinib at 3 and 6 mg/kg/day to methotrexate, with a randomi

Project: Other project

StatusFinished
Effective start/end date3/4/112/28/16

Funding

  • AB Science